Average Co-Inventor Count = 4.73
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vertex Pharmaceuticals, Inc. (16 from 1,153 patents)
2. Washington University (9 from 1,591 patents)
3. Fimbrion Therapeutics, Inc. (5 from 5 patents)
4. Glaxosmithkline Intellectual Property Development Limited (4 from 230 patents)
5. University of California (1 from 15,528 patents)
6. Astrazeneca Ab (1 from 1,501 patents)
7. Vyera Pharmaceuticals, LLC (1 from 3 patents)
31 patents:
1. 12351597 - Substituted biphenyl or phenylheteroaryl-mannosides as antagonists of FimH
2. 12297223 - Compounds
3. 11773127 - Compounds and methods for treating bacterial infections
4. 11697665 - C-mannoside compounds useful for the treatment of urinary tract infections
5. 11518761 - CDPK1 inhibitors, compositions, and methods related thereto
6. 11208411 - Compositions and methods for treating parasitic diseases
7. 11130780 - Inhibitors of growth factor activation enzymes
8. 11111262 - C-mannoside compounds useful for the treatment of urinary tract infections
9. 10844023 - Small molecule regulators of mitochondrial fusion and methods of use thereof
10. 10738070 - Mannose-derived antagonists of FimH useful for treating disease
11. 10273260 - Compounds and methods for treating bacterial infections
12. 9957289 - Compounds and methods for treating bacterial infections
13. 9567362 - Compounds and methods for treating bacterial infections
14. 8937167 - Compounds and methods for treating bacterial infections
15. 8691848 - Inhibitors of caspases